anti-Akt phospho (Thr342) antibody
ARG54951
ApplicationsWestern Blot
Product group Antibodies
ReactivityDrosophila
TargetAkt1
Overview
- SupplierArigo Biolaboratories
- Product Nameanti-Akt phospho (Thr342) antibody
- Delivery Days Customer23
- ApplicationsWestern Blot
- CertificationResearch Use Only
- ClonalityPolyclonal
- ConjugateUnconjugated
- Gene ID41957
- Target nameAkt1
- Target descriptionAkt1
- Target synonymsAkt; Akt kinase; AKT/PKB; Akt1; Akt1|PKB; Akt1-PA; Akt1-PB; Akt1-PC; Akt1-PD; Akt1-PE; CG4006; CG4006-PA; CG4006-PB; CG4006-PC; CG4006-PD; CG4006-PE; DAKT; D-Akt; dAkt kinase; dAKT/dPKB; dAkt/PKB; dAkt1; DAKT1/PKB; Dmel\CG4006; Dmel_CG4006; Dpkb; DRAC-PK; DRAC-PK66; DRAC-PK85; l(3)04226; l(3)89Bq; pAkt; p-Akt; PKB; PKB/AKT; PKB/dAKT; protein kinase B; RAC; RAC serine/threonine protein kinase; RacPK; related to PKA to PKC protein kinases; related to the A and C kinases
- HostRabbit
- IsotypeIgG
- Modification TypePhosphorylated
- Scientific DescriptionThe serine-threonine protein kinase encoded by the AKT1 gene is catalytically inactive in serum-starved primary and immortalized fibroblasts. AKT1 and the related AKT2 are activated by platelet-derived growth factor. The activation is rapid and specific, and it is abrogated by mutations in the pleckstrin homology domain of AKT1. It was shown that the activation occurs through phosphatidylinositol 3-kinase. In the developing nervous system AKT is a critical mediator of growth factor-induced neuronal survival. Survival factors can suppress apoptosis in a transcription-independent manner by activating the serine/threonine kinase AKT1, which then phosphorylates and inactivates components of the apoptotic machinery. Mutations in this gene have been associated with the Proteus syndrome. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2011]
- ReactivityDrosophila
- Storage Instruction-20°C
- UNSPSC12352203